阿片类药物与口服P2Y12受体抑制剂：一种药物相互作用。 - Suppr

Suppr

超能文献

Opioids and oral P2Y12 receptor inhibitors: A drug-drug interaction.

作者信息

Kubica Jacek

机构信息

Department of Cardiology and Internal Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.

出版信息

Cardiol J. 2022;29(5):727-729. doi: 10.5603/CJ.2022.0082.

DOI:10.5603/CJ.2022.0082

PMID:36196657

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9550322/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c6f/9550322/5be11f6a151f/cardj-29-5-727f1.jpg

相似文献

Opioids and oral P2Y12 receptor inhibitors: A drug-drug interaction.

Cardiol J. 2022;29(5):727-729. doi: 10.5603/CJ.2022.0082.

Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.

Circ Cardiovasc Interv. 2015 Nov;8(11):e002786. doi: 10.1161/CIRCINTERVENTIONS.115.002786.

Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.

JACC Cardiovasc Interv. 2016 Jun 13;9(11):1089-98. doi: 10.1016/j.jcin.2016.02.039. Epub 2016 Mar 21.

Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes.

Clin Res Cardiol. 2022 Jul;111(7):838-842. doi: 10.1007/s00392-021-01976-y. Epub 2021 Dec 1.

Prasugrel Versus Ticagrelor: Uncertainty Remains.

Circulation. 2016 Nov 22;134(21):1613-1616. doi: 10.1161/CIRCULATIONAHA.116.025113.

A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis.

Cardiovasc Revasc Med. 2017 Mar;18(2):79-85. doi: 10.1016/j.carrev.2016.10.005. Epub 2016 Oct 21.

Prasugrel in the treatment of acute coronary syndrome.

Future Cardiol. 2020 Nov;16(6):559-568. doi: 10.2217/fca-2020-0018. Epub 2020 May 11.

Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome.

Thromb Haemost. 2015 Oct;114(4):702-7. doi: 10.1160/TH15-02-0149. Epub 2015 Aug 27.

Is platelet function testing at the acute phase under P2Y inhibitors helpful in predicting bleeding in real-life patients with acute coronary syndrome? The AVALANCHE study.

Arch Cardiovasc Dis. 2021 Oct;114(10):612-623. doi: 10.1016/j.acvd.2021.06.003. Epub 2021 Jul 15.

Potent P2Y12 Inhibitors and Bleeding Complications.

Turk Kardiyol Dern Ars. 2022 Oct;50(7):543-544. doi: 10.5543/tkda.2022.22546.

引用本文的文献

Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint.

Cardiol J. 2025;32(2):189-194. doi: 10.5603/cj.99973. Epub 2025 Mar 20.

Negative Impact of ST-Segment Elevation Myocardial Infarction and Morphine Dose on Ticagrelor Uptake and Pharmacodynamics: A Population PK/PD Analysis of Pooled Individual Participant Data.

Clin Pharmacokinet. 2023 Jun;62(6):905-920. doi: 10.1007/s40262-023-01243-5. Epub 2023 Apr 25.

本文引用的文献

Comparative effects of fentanyl versus morphine on platelet inhibition induced by ticagrelor in patients with ST-segment elevation myocardial infarction: Full results of the PERSEUS randomized trial.

Cardiol J. 2022;29(4):591-600. doi: 10.5603/CJ.a2022.0049. Epub 2022 Jun 28.

The impact of mild therapeutic hypothermia on platelet reactivity in comatose survivors of cardiac arrest with acute myocardial infarction treated with ticagrelor.

Cardiol J. 2024;31(3):472-478. doi: 10.5603/CJ.a2022.0029. Epub 2022 May 6.

Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study.

Cardiol J. 2022;29(2):324-328. doi: 10.5603/CJ.a2021.0126. Epub 2021 Oct 13.

Modified ticagrelor loading doses according to the vasodilator-stimulated phosphoprotein phosphorylation index improve the clinical outcome in ST-elevation myocardial infarction patients with high on-treatment platelet reactivity.

Cardiol J. 2023;30(5):771-780. doi: 10.5603/CJ.a2021.0105. Epub 2021 Sep 28.

Pharmacokinetic Modeling of Morphine's Effect on Plasma Concentrations of Ticagrelor and Its Metabolite in Healthy Volunteers.

Front Physiol. 2021 Jun 24;12:663170. doi: 10.3389/fphys.2021.663170. eCollection 2021.

Ticagrelor effectively inhibits platelet aggregation in comatose survivors of cardiac arrest undergoing primary percutaneous coronary intervention treated with mild therapeutic hypothermia.

Cardiol J. 2023;30(4):636-645. doi: 10.5603/CJ.a2021.0064. Epub 2021 Jun 24.

Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Myocardial and Microvascular Injury in Acute Myocardial Infarction: Insights From the Randomized MonAMI Trial.

J Am Heart Assoc. 2021 May 4;10(9):e018881. doi: 10.1161/JAHA.120.018881. Epub 2021 Apr 26.

ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial.

BMJ Open. 2021 Mar 1;11(3):e043330. doi: 10.1136/bmjopen-2020-043330.

Oral NAloxone to overcome the moRphine effect in acute COronary syndrome patients treated with TICagrelor - NARCOTIC trial.

Cardiol J. 2022;29(3):432-440. doi: 10.5603/CJ.a2020.0040. Epub 2020 Mar 24.

Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta-Analysis.

Clin Pharmacol Ther. 2020 Jul;108(1):54-62. doi: 10.1002/cpt.1798. Epub 2020 Feb 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验